- Friday, August 26, 2022
- IPC GENERAL
- Industry
On August 22, Arcutis Biotherapeutics, Inc announced Arcutis Cares, a patient assistance program (PAP) for financially qualified uninsured and underinsured patients. Arcutis Cares is the first ever patient assistance program (PAP) for a topical psoriasis product, and it is now open for enrollment. Those who are eligible might be able to receive ZORYVE (roflumilast) cream 0.3% at no cost.
